EMPEROR-Pooled: effect of empagliflozin on serious adverse renal outcomes in chronic heart failure – a prospective alpha-protected, Individual patient-level pooled analysis
27 August 2021 (00:00 - 00:00)
Organised by:
About the speaker
Baylor University Medical Center, Dallas (United States of America)
4 More presentations in this session
Access the full session
The Event
ESC Congress 2021 - The Digital Experience
27 August - 30 August 2021
You may be interested in
Congress Presentation
